The oral arguments in Monday's Myriad appeal are online here. (Scroll down and look for Association for Molecular [Pathology] v. PTO).
- Log in to post comments
More like this
On Bioephemera, Jessica Palmer considers the evolving relationship between patent law and DNA, as the Court of Appeals for the Federal Circuit hears the appeal of Association for Molecular Pathology v. U.S. Patent and Trademark Office. At stake are patents that Myriad Genetics holds on two genes—…
Tomorrow morning, a three-judge panel of the Court of Appeals for the Federal Circuit will hear arguments in the appeal of Association for Molecular Pathology v. U.S. Patent and Trademark Office - better known as the Myriad gene patent case.* It has the patent and genetic blogospheres in a bit of…
Earlier this week, the American Civil Liberties Union and several other groups filed suit against Myriad Genetics -- the company that holds the patent on the breast cancer gene. They're hoping to get the breast cancer gene patent revoked, but more than that, they're aiming to stop gene patenting…
Some interesting news about the breast cancer patent lawsuit I wrote about for Slate's Double X Magazine a few months ago: A federal district court has just agreed to hear the case. When the lawsuit was first filed, many legal experts I talked to said they were sure the case would get thrown out…